Clene Inc (CLNN)
0.3772
-0.01
(-2.18%)
USD |
NASDAQ |
May 17, 16:00
0.3772
0.00 (0.00%)
After-Hours: 20:00
Clene Max Drawdown (5Y): 98.40% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 98.40% |
| March 31, 2024 | 98.40% |
| February 29, 2024 | 98.40% |
| January 31, 2024 | 98.40% |
| December 31, 2023 | 98.40% |
| November 30, 2023 | 97.68% |
| October 31, 2023 | 97.61% |
| September 30, 2023 | 97.16% |
| August 31, 2023 | 95.95% |
| July 31, 2023 | 95.51% |
| June 30, 2023 | 95.22% |
| May 31, 2023 | 94.60% |
| April 30, 2023 | 94.36% |
| March 31, 2023 | 94.36% |
| February 28, 2023 | 94.36% |
| January 31, 2023 | 94.36% |
| December 31, 2022 | 94.36% |
| November 30, 2022 | 94.36% |
| October 31, 2022 | 93.93% |
| September 30, 2022 | 87.12% |
| August 31, 2022 | 87.12% |
| July 31, 2022 | 87.12% |
| June 30, 2022 | 87.12% |
| May 31, 2022 | 87.12% |
| April 30, 2022 | 85.15% |
| Date | Value |
|---|---|
| March 31, 2022 | 85.15% |
| February 28, 2022 | 84.54% |
| January 31, 2022 | 84.54% |
| December 31, 2021 | 75.77% |
| November 30, 2021 | 71.47% |
| October 31, 2021 | 66.69% |
| September 30, 2021 | 58.10% |
| August 31, 2021 | 57.18% |
| July 31, 2021 | 57.18% |
| June 30, 2021 | 57.18% |
| May 31, 2021 | 57.18% |
| April 30, 2021 | 50.73% |
| March 31, 2021 | 50.73% |
| February 28, 2021 | 50.73% |
| January 31, 2021 | 50.73% |
| December 31, 2020 | 30.53% |
| November 30, 2020 | 3.19% |
| October 31, 2020 | 3.19% |
| September 30, 2020 | 3.19% |
| August 31, 2020 | 3.19% |
| July 31, 2020 | 3.19% |
| June 30, 2020 | 3.19% |
| May 31, 2020 | 3.19% |
| April 30, 2020 | 3.19% |
| March 31, 2020 | 3.19% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
0.81%
Minimum
May 2019
98.40%
Maximum
Dec 2023
56.20%
Average
69.08%
Median
Max Drawdown (5Y) Benchmarks
| CEL-SCI Corp | 96.13% |
| AIM ImmunoTech Inc | 99.76% |
| IGC Pharma Inc | 97.77% |
| NovaBay Pharmaceuticals Inc | 99.91% |
| Protalix BioTherapeutics Inc | 94.35% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -54.16 |
| Beta (5Y) | 0.4723 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 81.09% |
| Historical Sharpe Ratio (5Y) | -0.603 |
| Historical Sortino (5Y) | -1.048 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 37.11% |